Abstract

The launch of Value in Health Regional Issues in 2012 represented an important milestone in the development of pharmacoeconomics and outcomes research (PE-OR) in Asia, Central and Eastern Europe, Western Asia, Africa, and Latin America [1-2]. It was clear that a new journal was required to accommodate the rapid growth in studies. In the last 10 years, the sister journal Value in Health published considerably more articles originating in these regions, because of both an increase in submissions and the publication of the best articles from ISPOR’s Asian and Latin American conferences. We can only expect the volume of research from these regions to increase, given the combined size of their population and the rapid growth in interest in PE-OR studies.